EmitBio™ is a biotechnology company with products in the discovery, pre-clinical, and clinical stages of development. The Company’s proprietary technology platform uses precisely engineered light to stimulate physiological signals and initiate healing at the cellular level. While initially focused on an at-home treatment for COVID-19, EmitBio targets to deploy a family of products to redefine the standard of care for respiratory disease. EmitBio Inc. is headquartered in Durham, North Carolina and is an operating subsidiary of KNOW Bio, LLC.